EGFR mutation detected and taking Iressa 13501239552 Iressa

Bold body, ',', Iressa (gefitinib) is a new type of small molecular weight tumor treatment drug. Its mechanism of action is mainly to block conduction and inhibit the proliferation of tumor cells by inhibiting autophosphorylation. , to achieve targeted therapy. Clinically, it is mainly used to treat locally advanced or metastatic non-small cell lung cancer that has received chemotherapy in the past. It is especially effective for lung adenocarcinoma. The efficacy for squamous cell carcinoma is lower than that for adenocarcinoma and alveolar carcinoma. However, a large amount of clinical data shows that according to lung cancer The actual situation of the patients: After treatment with Iressa (gefitinib), some patients with lung squamous cell carcinoma and other non-small cell lung cancer still have obvious effects and are well tolerated.
/ boldface, ',',
/ boldface, ',', boldface, ',', manufacturer Indian Pharmaceuticals
/ boldface, ',', boldface, ',', trade name Iressa
/ bold type, ',', bold type, ',', generic name gefitinib
/ bold type, ',',
/ bold type, ',', bold type, ',', Iressa, gefitinib tablets
/ boldface, ',', boldface, ',', English name
/ boldface, ',', boldface, ',', specifications *Indian plates/bottles
/ 黑体, ',', 黑体, ',', Store below ℃ in the original packaging (just keep it in a cool place indoors)
/ 黑体, ',' , boldface, ',', validity year
/ boldface, ',',
/ boldface, ',',